Crohn's disease - infliximab (review) and adalimumab: committee meeting
Following on from the email update you received in March regarding the delay to the use of tumour necrosis factor alpha (TNF a) inhibitors (adalimumab, and infliximab [review]) for Crohn's disease appraisal, we can now confirm that the first Appraisal Committee meeting for will be held on 20 August 2008.
You can expect a set of papers for consultation during September 2008.
We will keep you informed of if there are any other changes. If you have any queries, please contact me at firstname.lastname@example.org or by phone: 020 7045 2243.
This page was last updated: 30 March 2010